Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans' protection against the virus.
Sep 25, 2021
0
51
With the race on to find a coronavirus vaccine, the biotech sector—from an investor's point of view—appears to be the new gold rush, promising often giddy returns, but analysts warn that the exuberance could be exaggerated.
Aug 18, 2020
0
3
Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world's biggest drug developers are tapping into the growing treatment market.
Nov 16, 2023
0
0
